BRPI0414694A - pró-fármaco(s) aciloximetilcarbamato de oxazolidinonas - Google Patents

pró-fármaco(s) aciloximetilcarbamato de oxazolidinonas

Info

Publication number
BRPI0414694A
BRPI0414694A BRPI0414694-8A BRPI0414694A BRPI0414694A BR PI0414694 A BRPI0414694 A BR PI0414694A BR PI0414694 A BRPI0414694 A BR PI0414694A BR PI0414694 A BRPI0414694 A BR PI0414694A
Authority
BR
Brazil
Prior art keywords
acyloxymethylcarbamate
oxazolidinone
prodrug
present
gram
Prior art date
Application number
BRPI0414694-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Vara Prasad Venkata Na Josyula
Robert C Gadwood
Lisa Marie Thomasco
Ji-Young Kim
Allison Laura Choy
Frederick Earl Boyer
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of BRPI0414694A publication Critical patent/BRPI0414694A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0414694-8A 2003-09-23 2004-09-13 pró-fármaco(s) aciloximetilcarbamato de oxazolidinonas BRPI0414694A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50532903P 2003-09-23 2003-09-23
PCT/IB2004/002983 WO2005028473A1 (fr) 2003-09-23 2004-09-13 Bioprecurseurs acyloxymethylcarbamate des oxazolidinones

Publications (1)

Publication Number Publication Date
BRPI0414694A true BRPI0414694A (pt) 2006-11-28

Family

ID=34375571

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414694-8A BRPI0414694A (pt) 2003-09-23 2004-09-13 pró-fármaco(s) aciloximetilcarbamato de oxazolidinonas

Country Status (10)

Country Link
US (1) US7265140B2 (fr)
EP (1) EP1668005B1 (fr)
JP (1) JP2007505890A (fr)
AT (1) ATE353894T1 (fr)
BR (1) BRPI0414694A (fr)
CA (1) CA2539848A1 (fr)
DE (1) DE602004004808T2 (fr)
ES (1) ES2278342T3 (fr)
MX (1) MXPA06003124A (fr)
WO (1) WO2005028473A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076798A2 (fr) 2003-02-26 2004-09-10 Enventure Global Technology Appareil d'expansion radiale et de deformation plastique d'un element tubulaire
KR20110097942A (ko) * 2003-08-20 2011-08-31 제노포트 인코포레이티드 아실옥시알킬 카르바메이트 프로드러그, 합성 및 사용 방법
ES2405329T3 (es) * 2003-12-30 2013-05-30 Xenoport, Inc. Síntesis de profármacos de carbarnato de aciloxialquilo y productos intermedios de los mismos
WO2005113520A1 (fr) * 2004-05-20 2005-12-01 Pharmacia & Upjohn Company Llc 2,3,5-trifluorphenyl oxazolidinones substitues a utiliser en tant qu'agents antibacteriens
DE102006007146A1 (de) 2006-02-16 2007-08-23 Bayer Healthcare Ag Aminoacyl-Prodrugs
CA2645031A1 (fr) 2006-03-07 2007-09-13 Bristol-Myers Squibb Company Composes de promedicament de pyrrolotriazine aniline utiles en tant qu'inhibiteurs de la kinase
US7776855B2 (en) * 2006-07-27 2010-08-17 Janssen Pharmaceutica N.V. Antimicrobial oxazolidinone prodrugs
DE102006039589A1 (de) 2006-08-24 2008-03-06 Bayer Healthcare Ag Aminoacyl-Prodrugs II
DE102007028407A1 (de) * 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
DE102007028319A1 (de) * 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
DE102007032345A1 (de) * 2007-07-11 2009-01-15 Bayer Healthcare Ag Aminoacyl-Prodrugs
DE102007032344A1 (de) 2007-07-11 2009-01-15 Bayer Healthcare Ag Prodrug-Derivate von 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxamid
DE102007032347A1 (de) 2007-07-11 2009-01-15 Bayer Healthcare Ag Aminoacyl-Prodrugs
US20100069441A1 (en) 2008-09-02 2010-03-18 Mikhail Fedorovich Gordeev Antimicrobial indoline compounds for treatment of bacterial infections
CN101798302B (zh) 2009-02-06 2014-11-05 上海盟科药业有限公司 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
DE102010028362A1 (de) 2010-04-29 2011-11-03 Bayer Schering Pharma Aktiengesellschaft Herstellverfahren
US20120065170A1 (en) 2010-09-10 2012-03-15 Micurx Pharmaceuticals, Inc. Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
WO2013088255A1 (fr) * 2011-12-15 2013-06-20 Alkermes Pharma Ireland Limited Promédicaments de composés amine secondaires
US9145411B2 (en) 2012-08-02 2015-09-29 Asana Biosciences, Llc Substituted amino-pyrimidine derivatives
CN105612166B (zh) 2014-02-21 2019-02-19 上海盟科药业有限公司 治疗用水溶性(o-羰基)氨基磷酸酯前药
GB201518950D0 (en) * 2015-10-27 2015-12-09 Glaxosmithkline Ip Dev Ltd Compound
WO2019037791A1 (fr) * 2017-08-25 2019-02-28 广州市恒诺康医药科技有限公司 Promédicament de rasagiline à action prolongée, son procédé de préparation et son utilisation
WO2021184339A1 (fr) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Composé d'oxazolidinone et procédés d'utilisation de celui-ci comme agent antibactérien
JP2024516114A (ja) * 2021-04-07 2024-04-12 コスマス セラピューティックス ディベロップメント インコーポレイテッド メラトニン受容体の新規調節因子、ならびにその製造方法および使用
EP4441066A1 (fr) * 2021-11-29 2024-10-09 Hongene Biotech Corporation Synthèse de nucléosides protégés 2' acétyl-ester
CN119431373B (zh) * 2024-07-24 2025-08-08 科睿迪(南京)医药科技有限公司 一种β-内酰胺酶抑制剂及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2228647A1 (fr) 1995-09-01 1997-03-13 Pharmacia & Upjohn Company Pheniloxazolidinones presentant une liaison c-c avec des structures heterocycliques a 4-8 elements
EP1133493A1 (fr) * 1998-11-27 2001-09-19 PHARMACIA & UPJOHN COMPANY Agents antibacteriens oxazolidinone a fonction thiocarbonyle
EA005567B1 (ru) * 1999-12-21 2005-04-28 Фармация Энд Апджон Компани Оксазолидиноны, обладающие сульфоксиминовой функциональностью
GB0108793D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0108764D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
JP4208243B2 (ja) * 2002-01-24 2009-01-14 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗微生物性ジヒドロチアジンおよびジヒドロチオピランオキサゾリジノン
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
EP1668005A1 (fr) 2006-06-14
ATE353894T1 (de) 2007-03-15
DE602004004808T2 (de) 2007-12-06
US20050267104A1 (en) 2005-12-01
EP1668005B1 (fr) 2007-02-14
MXPA06003124A (es) 2006-06-20
CA2539848A1 (fr) 2005-03-31
ES2278342T3 (es) 2007-08-01
JP2007505890A (ja) 2007-03-15
US7265140B2 (en) 2007-09-04
WO2005028473A1 (fr) 2005-03-31
DE602004004808D1 (de) 2007-03-29

Similar Documents

Publication Publication Date Title
DE602004004808D1 (de) Acyloxymethylcarbamat-prodrugs von oxazolidinonen
MX351589B (es) Antibioticos de oxazolidinona.
HUP0400446A2 (hu) Azitromicin kristályformái
DE60327438D1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
CO5570678A2 (es) N-alquilo-4-metileneamino-3-hidroxilo-2-piridonas como anti- microbianos
IL187904A (en) Use of quinoline derivatives for the preparation of bacterial preparations for the treatment of bacteria caused by bacteria
GEP20094834B (en) Macrolides, pharmaceutical compositions containing them and their use for treatment of bacterial infections
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
ES2186550B2 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
DE602004012269D1 (de) Quervernetzte glycopeptid-cephalosporin-antibiotika
DE602004024393D1 (de) Quervernetzte glycopeptid-cephalosporin-antibiotika
NO20055893L (no) Nye linkomycinderivativer med antimikrobiell aktivitet
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
UY28542A1 (es) Amidas macrocíclicas antibacterianas
TW200740800A (en) Oxazolidinone compounds, and compositions and methods related thereto
WO2006120563A3 (fr) Agents antibacteriens
DK1656143T3 (da) Quinolon-antibiotika til behandling af periodontale infektioner
DK1558580T3 (da) N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner
ATE449775T1 (de) Carbacephem beta-lactam-antibiotika
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
EA200800151A1 (ru) Производные хинолина в качестве антибактериальных агентов
DE502005010850D1 (de) Antibakterielle amid-makrozyklen iv
MY142727A (en) Preventing vertical endoparasite infections
DK1516626T3 (da) Teicoplanin-sammensætning med forbedret antibiotisk aktivitet
CL2004001343A1 (es) Compuesto derivado del ester de 3,3-dimetil-4,4,7-trioxo-4-tia-1-aza-biciclo [3.2.0]-heptano-2-carboxilico, composicion farmaceutica, inhibidores de beta lactama, utiles para tratar una infeccion bacteriana.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.